Skip to main content
. 2017 Nov 1;15(1):345–350. doi: 10.3892/etm.2017.5429

Figure 3.

Figure 3.

Expression of miR-21 in different clinical features. (A) miR-21 was significant higher in patients with low level of complement component 3. And no significant difference was found in (B) nephritis, (C) arthritis, (D) ulceration, (E) pleurisy, (F) rash and (G) anti-double stranded DNA. Values are expressed as the mean ± standard error of the mean. *P<0.05 vs. control. n.s., no significance; miR, microRNA.